Aurbindo to merge subsidiary Trident Life Sciences Ltd
13 Nov 2009
The board of directors, of drug manufacturer, Aurobindo Pharma has approved the draft scheme of amalgamation for the merger of Trident Life Sciences Ltd, the company disclosed ysterday.
According the scheme the company's subsidiary Trident Life Sciences Ltd, will be merged with Aurobindo Pharma.
In its filing to the Bombay Stock Exchange the company said upon the scheme taking effect all assets and liabilities of Trident would be transferred to Aurobindo.
No shares will be issued with the merger as Trident is a subsidiary of Aurobindo.
The filing says the scheme would be subject to various approvals etc as required.
The company's annual general meeting of the shareholder is scheduled for 23 December 2009.
Trident Life Sciences Ltd is a research organisation set up for providing high quality services on par with global standards for the indigenous drug industry.